Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine
Andrew Catanzaro(National Institutes of Health), Barney S. Graham(National Institutes of Health), Mary E. Enama(National Institutes of Health), Martha Nason(National Institutes of Health), Gary J. Nabel(National Institutes of Health), Robert T. Bailer(National Institutes of Health), John R. Mascola(National Institute of Allergy and Infectious Diseases), Steve Rucker(National Institutes of Health), Phillip L. Gomez(National Institutes of Health), Mario Roederer(National Institutes of Health), Charla Andrews(National Institutes of Health), Julie E. Martin(National Institutes of Health), Richard A. Koup(Aaron Diamond AIDS Research Center)
Cited by 153
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k